Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2021

01-06-2021 | Commentary

Shared decision making for psychiatric medication management: a summary of its uptake, barriers and facilitators

Authors: Deena M. Ashoorian, Rowan M. Davidson

Published in: International Journal of Clinical Pharmacy | Issue 3/2021

Login to get access

Abstract

The model of shared decision making with mental health patients and clinicians (doctors and pharmacists) harnesses the benefits of patients becoming partners in their own recovery through improved communication and greater self-advocacy. Shared decision making in mental health services is an emerging model of care which has not been well investigated, however it is seen as the way forward to achieving improved health outcomes for non-pharmacological and pharmacological therapy. Successful implementation of this model requires supporting the process through provision of information and training, use of decision aids, coaching in communication skills and inclusion of family and carers in the decision making process. This summary examines the application of the shared decision making model for psychiatric medication management, including barriers and facilitators.
Appendix
Available only for authorised users
Literature
1.
go back to reference Australian institute of health and welfare. Mental health-related prescriptions. Mental health services in Australia; 2019. Australian institute of health and welfare. Mental health-related prescriptions. Mental health services in Australia; 2019.
2.
go back to reference Australian Health Ministers Advisory Council. A national framework for recovery-orientated mental health services: guide for practitioners and providers. Canberra: Commonwealth of Australia; 2013. Australian Health Ministers Advisory Council. A national framework for recovery-orientated mental health services: guide for practitioners and providers. Canberra: Commonwealth of Australia; 2013.
3.
go back to reference Deegan PE. The lived experience of using psychiatric medication in the recovery process and a shared decision-making program to support it. Psychiatr Rehabil J. 2007;31(1):62–9.CrossRef Deegan PE. The lived experience of using psychiatric medication in the recovery process and a shared decision-making program to support it. Psychiatr Rehabil J. 2007;31(1):62–9.CrossRef
4.
go back to reference Adams JR, Drake RE, Wolford GL. Shared decision-making preferences of people with severe mental illness. Psychiatr Serv. 2007;58(9):1219–21.CrossRef Adams JR, Drake RE, Wolford GL. Shared decision-making preferences of people with severe mental illness. Psychiatr Serv. 2007;58(9):1219–21.CrossRef
5.
go back to reference Morant N, Kaminskiy E, Ramon S. Shared decision making for psychiatric medication management: beyond the micro-social. Health Expect. 2015;19(5):1002–14.CrossRef Morant N, Kaminskiy E, Ramon S. Shared decision making for psychiatric medication management: beyond the micro-social. Health Expect. 2015;19(5):1002–14.CrossRef
6.
go back to reference Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681–92.CrossRef Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681–92.CrossRef
7.
go back to reference Shepherd A, Shorthouse O, Gask L. Consultant psychiatrists’ experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study. BMC Psychiatry. 2014;14:127.CrossRef Shepherd A, Shorthouse O, Gask L. Consultant psychiatrists’ experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study. BMC Psychiatry. 2014;14:127.CrossRef
8.
go back to reference Bradley E, Green D. Involved, inputting or informing: “Shared” decision making in adult mental health care. Health Expect. 2018;21(1):192–200.CrossRef Bradley E, Green D. Involved, inputting or informing: “Shared” decision making in adult mental health care. Health Expect. 2018;21(1):192–200.CrossRef
9.
go back to reference Finnerty MT, Layman DM, Chen Q, Leckman-Westin E, Bermeo N, Ng-Mak DS, et al. Use of a web-based shared decision-making program: impact on ongoing treatment engagement and antipsychotic adherence. Psychiatr Serv. 2018;69(12):1215–21.CrossRef Finnerty MT, Layman DM, Chen Q, Leckman-Westin E, Bermeo N, Ng-Mak DS, et al. Use of a web-based shared decision-making program: impact on ongoing treatment engagement and antipsychotic adherence. Psychiatr Serv. 2018;69(12):1215–21.CrossRef
10.
go back to reference Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Related Outcome Measures. 2014;5:43–62.CrossRef Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Related Outcome Measures. 2014;5:43–62.CrossRef
11.
go back to reference McGrath P. ‘A very individual thing’: findings on drug therapy in psychiatry from the perspective of Australian consumers. Australian e-J Adv Mental Health. 2007;6(3):1. McGrath P. ‘A very individual thing’: findings on drug therapy in psychiatry from the perspective of Australian consumers. Australian e-J Adv Mental Health. 2007;6(3):1.
12.
go back to reference Nosè M, Maria M, Eleonora E, Marco B, Paola P, Giovanni O, et al. Adverse effects of antipsychotic drugs: survey of doctors’ versus patients’ perspective. Soc Psychiatry Psychiatr Epidemiol. 2012;47(1):157–64.CrossRef Nosè M, Maria M, Eleonora E, Marco B, Paola P, Giovanni O, et al. Adverse effects of antipsychotic drugs: survey of doctors’ versus patients’ perspective. Soc Psychiatry Psychiatr Epidemiol. 2012;47(1):157–64.CrossRef
13.
go back to reference Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry. 2012;12(1):87.CrossRef Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry. 2012;12(1):87.CrossRef
14.
go back to reference Perez-Revuelta J, Villagran-Moreno JM, Moreno-Sanchez L, Pascual-Pano JM, Gonzalez-Saiz F. Patient perceived participation in decision making on their antipsychotic treatment: evidence of validity and reliability of the COMRADE scale in a sample of schizophrenia spectrum disorders. Patient Educ Couns. 2018;101(8):1477–82.CrossRef Perez-Revuelta J, Villagran-Moreno JM, Moreno-Sanchez L, Pascual-Pano JM, Gonzalez-Saiz F. Patient perceived participation in decision making on their antipsychotic treatment: evidence of validity and reliability of the COMRADE scale in a sample of schizophrenia spectrum disorders. Patient Educ Couns. 2018;101(8):1477–82.CrossRef
15.
go back to reference Alguera-Lara V, Dowsey MM, Ride J, Kinder S, Castle D. Shared decision making in mental health: the importance for current clinical practice. Australas Psychiatry. 2017;25(6):578–82.CrossRef Alguera-Lara V, Dowsey MM, Ride J, Kinder S, Castle D. Shared decision making in mental health: the importance for current clinical practice. Australas Psychiatry. 2017;25(6):578–82.CrossRef
16.
go back to reference Miller R, Pavlo AJ. Two experts, one goal: collaborative deprescribing in psychiatry. Curr Psychiatry Rev. 2018;14(1):12–8.CrossRef Miller R, Pavlo AJ. Two experts, one goal: collaborative deprescribing in psychiatry. Curr Psychiatry Rev. 2018;14(1):12–8.CrossRef
17.
go back to reference Dahlqvist Jonsson P, Schon UK, Rosenberg D, Sandlund M, Svedberg P. Service users’ experiences of participation in decision making in mental health services. J Psychiatr Ment Health Nurs. 2015;22(9):688–97.CrossRef Dahlqvist Jonsson P, Schon UK, Rosenberg D, Sandlund M, Svedberg P. Service users’ experiences of participation in decision making in mental health services. J Psychiatr Ment Health Nurs. 2015;22(9):688–97.CrossRef
18.
go back to reference Delman J, Clark JA, Eisen SV, Parker VA. Facilitators and barriers to the active participation of clients with serious mental illnesses in medication decision making: the perceptions of young adult clients. J Behav Health Serv Res. 2015;42(2):238–53.CrossRef Delman J, Clark JA, Eisen SV, Parker VA. Facilitators and barriers to the active participation of clients with serious mental illnesses in medication decision making: the perceptions of young adult clients. J Behav Health Serv Res. 2015;42(2):238–53.CrossRef
19.
go back to reference Jorgensen K, Rendtorff JD. Patient participation in mental health care-perspectives of healthcare professionals: an integrative review. Scand J Caring Sci. 2018;32:490–501.CrossRef Jorgensen K, Rendtorff JD. Patient participation in mental health care-perspectives of healthcare professionals: an integrative review. Scand J Caring Sci. 2018;32:490–501.CrossRef
20.
go back to reference Patel SR, Bakken S, Ruland C. Recent advances in shared decision making for mental health. Curr Opin Psychiatry. 2008;21(6):606–12.CrossRef Patel SR, Bakken S, Ruland C. Recent advances in shared decision making for mental health. Curr Opin Psychiatry. 2008;21(6):606–12.CrossRef
21.
go back to reference Légaré F, Thompson-Leduc P. Twelve myths about shared decision making. Patient Educ Couns. 2014;96(3):281–6.CrossRef Légaré F, Thompson-Leduc P. Twelve myths about shared decision making. Patient Educ Couns. 2014;96(3):281–6.CrossRef
22.
go back to reference Mistler LA, Drake RE. Shared decision making in antipsychotic management. Journal of Psychiatric Practice. 2008;14(6):333–44.CrossRef Mistler LA, Drake RE. Shared decision making in antipsychotic management. Journal of Psychiatric Practice. 2008;14(6):333–44.CrossRef
23.
go back to reference Fukui S, Salyers MP, Rapp C, Goscha R, Young L, Mabry A. Supporting shared decision making beyond consumer-prescriber interactions: initial development of the commonGround fidelity scale. Am J Psychiatr Rehabil. 2016;19(3):252–67.CrossRef Fukui S, Salyers MP, Rapp C, Goscha R, Young L, Mabry A. Supporting shared decision making beyond consumer-prescriber interactions: initial development of the commonGround fidelity scale. Am J Psychiatr Rehabil. 2016;19(3):252–67.CrossRef
24.
go back to reference Paudel S, Sharma N, Joshi A, Randall M. Development of a shared decision making model in a community mental health center. Community Ment Health J. 2018;54(1):1–6.CrossRef Paudel S, Sharma N, Joshi A, Randall M. Development of a shared decision making model in a community mental health center. Community Ment Health J. 2018;54(1):1–6.CrossRef
25.
go back to reference Stein BD, Kogan JN, Mihalyo MJ, Schuster J, Deegan PE, Sorbero MJ, et al. Use of a computerized medication shared decision making tool in community mental health settings: impact on psychotropic medication adherence. Community Ment Health J. 2013;49(2):185–92.CrossRef Stein BD, Kogan JN, Mihalyo MJ, Schuster J, Deegan PE, Sorbero MJ, et al. Use of a computerized medication shared decision making tool in community mental health settings: impact on psychotropic medication adherence. Community Ment Health J. 2013;49(2):185–92.CrossRef
26.
go back to reference Ashoorian D, Davidson R, Rock D, Dragovic M, Clifford R. A clinical communication tool for the assessment of psychotropic medication side effects. Psychiatry Res. 2015;230(2):643–57.CrossRef Ashoorian D, Davidson R, Rock D, Dragovic M, Clifford R. A clinical communication tool for the assessment of psychotropic medication side effects. Psychiatry Res. 2015;230(2):643–57.CrossRef
27.
go back to reference Deegan PE, Carpenter-Song E, Drake RE, Naslund JA, Luciano A, Hutchison SL. Enhancing clients’ communication regarding goals for using psychiatric medications. Psychiatr Serv. 2017;68(8):771–5.CrossRef Deegan PE, Carpenter-Song E, Drake RE, Naslund JA, Luciano A, Hutchison SL. Enhancing clients’ communication regarding goals for using psychiatric medications. Psychiatr Serv. 2017;68(8):771–5.CrossRef
28.
go back to reference Hamann J, Kruse J, Schmitz FS, Kissling W, Pajonk FG. Patient participation in antipsychotic drug choice decisions. Psychiatry Res. 2008;178(1):63–7.CrossRef Hamann J, Kruse J, Schmitz FS, Kissling W, Pajonk FG. Patient participation in antipsychotic drug choice decisions. Psychiatry Res. 2008;178(1):63–7.CrossRef
29.
go back to reference Crickard EL, O’Brien MS, Rapp CA, Holmes CL. Developing a framework to support shared decision making for youth mental health medication treatment. Community Ment Health J. 2010;46(5):474–81.CrossRef Crickard EL, O’Brien MS, Rapp CA, Holmes CL. Developing a framework to support shared decision making for youth mental health medication treatment. Community Ment Health J. 2010;46(5):474–81.CrossRef
30.
go back to reference Tibaldi G, Salvador-carulla L, Carlos G-G. From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care. Curr Clin Pharmacol. 2011;6(2):91–9.CrossRef Tibaldi G, Salvador-carulla L, Carlos G-G. From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care. Curr Clin Pharmacol. 2011;6(2):91–9.CrossRef
31.
go back to reference Slade M. Implementing shared decision making in routine mental health care. World J Psychiatry. 2017;16(2):146–53.CrossRef Slade M. Implementing shared decision making in routine mental health care. World J Psychiatry. 2017;16(2):146–53.CrossRef
Metadata
Title
Shared decision making for psychiatric medication management: a summary of its uptake, barriers and facilitators
Authors
Deena M. Ashoorian
Rowan M. Davidson
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-021-01240-3

Other articles of this Issue 3/2021

International Journal of Clinical Pharmacy 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.